Sponsor pipeline

Kiniksa Pharmaceuticals International, plc clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 2		1
Phase 2/3		1

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 2/3
NCT07010159	Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and…	Pericarditis	Recruiting	2026-08-26
Phase 2
NCT07288216	Transition to KPL-387 Monotherapy Dosing & Administration Study	Recurrent Pericarditis	Recruiting	2026-09-30
Not specified
NCT04687358	REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients	Recurrent Pericarditis	Active, Not Recruiting	2026-02-17

Get alerts when Kiniksa Pharmaceuticals International, plc's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.